Table of Contents

company-logo

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to treat patients with MDD; and ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor for the treatment of cognitive impairment associated with schizophrenia. It also develops ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist to treat patients with MDD and higher levels of anhedonia, and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor for the treatment of MDD. In addition, the company develops novel pharmacodynamically synergistic combinations and an AI-enabled biomarker platform that combine sources of information on patients brain activity and behavior to identify patients to respond to novel product candidates. Alto Neuroscience, Inc. was incorporated in 2019 and is based in Los Altos, California.

Alto Neuroscience Dividend Announcement

• Alto Neuroscience does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Alto Neuroscience dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Alto Neuroscience Dividend History

Alto Neuroscience Dividend Yield

Alto Neuroscience current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Alto Neuroscience stock? Use our calculator to estimate your expected dividend yield:

Alto Neuroscience Financial Ratios

P/E ratio-2.62
PEG ratio0.03
P/B ratio0.73
ROE-82.97%
Payout ratio0.00%
Current ratio19.85
Quick ratio19.85
Cash Ratio19.62

Alto Neuroscience Dividend FAQ

Does Alto Neuroscience stock pay dividends?
Alto Neuroscience does not currently pay dividends to its shareholders.
Has Alto Neuroscience ever paid a dividend?
No, Alto Neuroscience has no a history of paying dividends to its shareholders. Alto Neuroscience is not known for its dividend payments.
Why doesn't Alto Neuroscience pay dividends?
There are several potential reasons why Alto Neuroscience would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Alto Neuroscience ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Alto Neuroscience has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Alto Neuroscience a dividend aristocrat?
Alto Neuroscience is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Alto Neuroscience a dividend king?
Alto Neuroscience is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Alto Neuroscience a dividend stock?
No, Alto Neuroscience is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Alto Neuroscience stocks?
To buy Alto Neuroscience you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Alto Neuroscience stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.